Insider Monkey - 2025-07-11 23:18
VYNE Therapeutics Inc. (NASDAQ:VYNE) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright have reaffirmed their Buy rating on VYNE Therapeutics Inc. (NASDAQ:VYNE), with a price target of $4.50, implying an upside of nearly 215%. This optimism follows the company’s advancement of its VYN202 program for moderate-to-severe plaque psoriasis. Just […]